Sanofi-aventis SNY US and Oxford University have entered into an agreement to conduct multi-phase oncology clinical and epidemiological research with INDOX, India's leading academic oncology network.
Through this partnership, sanofi-aventis US and its affiliates will have access to the expertise and experience of India's top oncologists and scientists to conduct clinical research.
SNYSanofi SA
$52.770.86%
Edge Rankings
Momentum
58.82
Growth
31.82
Quality
29.25
Value
50.22
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in